Literature DB >> 11382665

Determinants of serum enterolactone concentration.

A Kilkkinen1, K Stumpf, P Pietinen, L M Valsta, H Tapanainen, H Adlercreutz.   

Abstract

BACKGROUND: The lignan enterolactone, which is produced by the intestinal microflora from dietary precursors, may protect against hormone-dependent cancers and cardiovascular diseases.
OBJECTIVE: We examined the cross-sectional associations between the serum enterolactone concentration and variables related to diet and health in Finnish adults.
DESIGN: Serum enterolactone was measured by using time-resolved fluoroimmunoassay in 2380 Finnish men and women aged 25-64 y who were participating in a cross-sectional national survey in 1997. Background information was collected with self-administered questionnaires and the diet was assessed with a food-frequency questionnaire.
RESULTS: The median serum enterolactone concentration was 13.8 nmol/L (range: 0-95.6 nmol/L) in men and 16.6 nmol/L (range: 0-182.6 nmol/L) in women. Multiple regression analyses showed positive associations in men between the serum enterolactone concentration and constipation, consumption of whole-grain products, and intake of fruit and berries. In women, the serum enterolactone concentration was positively and independently associated with consumption of vegetables, subject age, and constipation and was negatively associated with smoking. Furthermore, female subjects of normal weight had significantly higher serum enterolactone concentrations than did their underweight or obese peers.
CONCLUSIONS: The serum enterolactone concentration varies widely in the population. Of the variables we examined, the most important determinants of the serum enterolactone concentration were consumption of lignan-containing foods and constipation; however, these appeared to explain only a small part of the variation. Therefore, the role of gut microflora in the metabolism of lignans might be very important. Further studies will also be needed to determine the bioavailability and absorption rate of lignans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11382665     DOI: 10.1093/ajcn/73.6.1094

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  34 in total

1.  Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.

Authors:  Carol J Fabian; Bruce F Kimler; Carola M Zalles; Jennifer R Klemp; Brian K Petroff; Qamar J Khan; Priyanka Sharma; Kenneth D R Setchell; Xueheng Zhao; Teresa A Phillips; Trina Metheny; Jennifer R Hughes; Hung-Wen Yeh; Karen A Johnson
Journal:  Cancer Prev Res (Phila)       Date:  2010-08-19

2.  Dietary phytoestrogen intake is associated with reduced colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan Okey; Patricia Harper
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

3.  Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans.

Authors:  Thomas Clavel; Gemma Henderson; Carl-Alfred Alpert; Catherine Philippe; Lionel Rigottier-Gois; Joël Doré; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

4.  Higher urinary lignan concentrations in women but not men are positively associated with shorter time to pregnancy.

Authors:  Sunni L Mumford; Rajeshwari Sundaram; Enrique F Schisterman; Anne M Sweeney; Dana Boyd Barr; Michael E Rybak; Jose M Maisog; Daniel L Parker; Christine M Pfeiffer; Germaine M Buck Louis
Journal:  J Nutr       Date:  2014-01-08       Impact factor: 4.798

5.  Plasma metabolite abundances are associated with urinary enterolactone excretion in healthy participants on controlled diets.

Authors:  Fayth L Miles; Sandi L Navarro; Yvonne Schwarz; Haiwei Gu; Danijel Djukovic; Timothy W Randolph; Ali Shojaie; Mario Kratz; Meredith A J Hullar; Paul D Lampe; Marian L Neuhouser; Daniel Raftery; Johanna W Lampe
Journal:  Food Funct       Date:  2017-09-20       Impact factor: 5.396

6.  A Prospective Investigation of the Association Between Urinary Excretion of Dietary Lignan Metabolites and Weight Change in US Women.

Authors:  Yang Hu; Yan Song; Adrian A Franke; Frank B Hu; Rob M van Dam; Qi Sun
Journal:  Am J Epidemiol       Date:  2015-08-18       Impact factor: 4.897

7.  Effect of dietary intervention on serum lignan levels in pregnant women - a controlled trial.

Authors:  Riitta Luoto; Elham Kharazmi; Niina M Saarinen; Annika I Smeds; Sari Mäkelä; Mahdi Fallah; Jani Raitanen; Leena Hilakivi-Clarke
Journal:  Reprod Health       Date:  2010-10-08       Impact factor: 3.223

8.  Sociodemographic and lifestyle variables are compound- and class-specific correlates of urine phytoestrogen concentrations in the U.S. population.

Authors:  Michael E Rybak; Maya R Sternberg; Christine M Pfeiffer
Journal:  J Nutr       Date:  2013-04-17       Impact factor: 4.798

9.  Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans.

Authors:  Kenneth D R Setchell; Nadine M Brown; Linda Zimmer-Nechemias; Brian Wolfe; Pinky Jha; James E Heubi
Journal:  Food Funct       Date:  2014-03       Impact factor: 5.396

10.  Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies.

Authors:  L S Velentzis; M M Cantwell; C Cardwell; M R Keshtgar; A J Leathem; J V Woodside
Journal:  Br J Cancer       Date:  2009-03-31       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.